Newsfeed : FDA Staff Supports Truvada PrEP in Advance of Hearing

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » May 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

May 9, 2012

FDA Staff Supports Truvada PrEP in Advance of Hearing

Staff from the Food and Drug Administration (FDA) have found Truvada, a pill from Gilead Sciences, to be safe and effective when used to protect HIV-negative people from getting the virus, Bloomberg Businessweek reports. Gilead would be the first company to sell a drug for pre-exposure prophylaxis (PrEP) treatment. FDA staff found Truvada to be “well-tolerated,” and they accepted data from two studies that supported its ability to reduce the risk of infection. Regulators have said that their main concerns are when and how it should be used, what tests should be required for patients and what information should be used for patients and doctors. FDA advisers will hold a hearing May 10 to consider approving Truvada as PrEP.  

To read the Bloomberg Businessweek article, click here.

Search: Truvada, Bloomberg Businessweek, Gilead, HIV, AIDS, PrEP, medication, treatment


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    TanyaB
    Delray Beach
    Florida


    youngbloodlatino
    Columbia
    Maryland


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.